Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 177 publications

Evinacumab Improved the Homozygous Familial Hypercholesterolemia Lipid Metabolism: A Case Report.

Evinacumab Improved the Homozygous Familial Hypercholesterolemia Lipid Metabolism: A Case Report.

Journal: Journal of atherosclerosis and thrombosis
Published: October 08, 2025

Discovery, Optimization, and Evaluation of Novel ANGPTL3 Modulators for the Treatment of Hyperlipidemia.

Discovery, Optimization, and Evaluation of Novel ANGPTL3 Modulators for the Treatment of Hyperlipidemia.

Journal: Journal of medicinal chemistry
Published: September 16, 2025

Dyslipidemias as rare diseases.

Dyslipidemias as rare diseases.

Journal: Casopis lekaru ceskych
Published: August 15, 2025

Correction to: Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia.

Correction to: Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia.

Journal: Circulation
Published: July 07, 2025

A Comprehensive Review of the Latest Approaches to Managing Hypercholesterolemia: A Comparative Analysis of Conventional and Novel Treatments: Part II.

A Comprehensive Review of the Latest Approaches to Managing Hypercholesterolemia: A Comparative Analysis of Conventional and Novel Treatments: Part II.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 30, 2025

Long-term safety and effectiveness of evinacumab in people with homozygous familial hypercholesterolemia: a plain language summary.

Long-term safety and effectiveness of evinacumab in people with homozygous familial hypercholesterolemia: a plain language summary.

Journal: Future cardiology
Published: June 23, 2025

ANGPTL3: A Breakthrough Target in Treatment for Dyslipidemia and Atherosclerosis.

ANGPTL3: A Breakthrough Target in Treatment for Dyslipidemia and Atherosclerosis.

Journal: Journal of atherosclerosis and thrombosis
Published: June 04, 2025

Real-World Effectiveness and Safety of Evinacumab in Children and Adults With Homozygous Familial Hypercholesterolemia: A Multisite US Perspective.

Real-World Effectiveness and Safety of Evinacumab in Children and Adults With Homozygous Familial Hypercholesterolemia: A Multisite US Perspective.

Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: May 29, 2025

Efficacy of evinacumab in patients with severe hypertriglyceridemia and a history of severe hypertriglyceridemia-related acute pancreatitis: A phase 2b trial.

Efficacy of evinacumab in patients with severe hypertriglyceridemia and a history of severe hypertriglyceridemia-related acute pancreatitis: A phase 2b trial.

Journal: Journal of clinical lipidology
Published: May 02, 2025

Multimodal Therapy Achieves Secondary Prevention LDL-C Targets in LDL-Receptor Null Homozygous Familial Hypercholesterolemia.

Multimodal Therapy Achieves Secondary Prevention LDL-C Targets in LDL-Receptor Null Homozygous Familial Hypercholesterolemia.

Journal: JACC. Case reports
Published: April 21, 2025

Breaking barriers: Innovative therapies for managing homozygous familial hypercholesterolemia.

Breaking barriers: Innovative therapies for managing homozygous familial hypercholesterolemia.

Journal: Experimental and molecular pathology
Published: March 26, 2025

Oligogenic Familial Hypercholesterolemia Treated by Combination Therapy of Statin, Ezetimibe, PCSK9 Inhibitor, and Lomitapide.

Oligogenic Familial Hypercholesterolemia Treated by Combination Therapy of Statin, Ezetimibe, PCSK9 Inhibitor, and Lomitapide.

Journal: Internal medicine (Tokyo, Japan)
Published: March 25, 2025
Showing 1-12 of 177

Last Updated: 10/31/2025